|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 16 October 2008
doi: 10.1242/dev.021238
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

1 Max-Planck-Institute of Immunobiology, Stuebeweg 51, D-79108 Freiburg,
Germany.
2 Institute for Developmental Biology, University of Cologne, D-50923 Cologne,
Germany.
Author for correspondence (e-mail:
mhammers{at}uni-koeln.de)
Accepted 1 October 2008
| SUMMARY |
|---|
|
|
|---|
Key words: Cyp26b1, Retinoic acid, Bmp2, Cartilage, Bone, Chondrocyte, Osteoblast, Osteopontin, Osterix, Craniofacial development, Vertebra, Zebrafish
| INTRODUCTION |
|---|
|
|
|---|
A known signal regulating skeletogenic cell development is all-trans
retinoic acid (RA) (Adams et al.,
2007
; Weston et al.,
2003
), a derivative of vitamin A that is required for multiple
processes of vertebrate development
(Niederreither and Dolle,
2008
). RA is a diffusible lipophilic molecule that binds to
nuclear receptors [retinoic acid receptors (RARs) and retinoid X receptors
(RXRs)] to regulate the transcription of target genes. RA concentrations are
determined by the balance between RA synthesis via retinaldehyde hydrogenases
(Aldh1-3) and RA oxidation by cytochrome P450 enzymes of the Cyp26 class
(Blomhoff and Blomhoff, 2006
;
Fujii et al., 1997
;
White et al., 1997
). As in
mammals, three different zebrafish cyp26 genes have been described:
cyp26a1, cyp26b1 and cyp26c1 (formerly cyp26d1),
which are expressed in distinct, but partially overlapping patterns
(Abu-Abed et al., 2002
;
Emoto et al., 2005
;
Gu et al., 2005
;
Hernandez et al., 2007
;
Kudoh et al., 2002
;
MacLean et al., 2001
;
Tahayato et al., 2003
;
Zhao et al., 2005
). The in
vivo requirement for Cyp26 enzymes was revealed via Cyp26a1 and
Cyp26b1 gene targeting in mouse
(Abu-Abed et al., 2001
;
MacLean et al., 2007
;
Yashiro et al., 2004
), and via
cyp26a1 (giraffe) mutants
(Emoto et al., 2005
) and
antisense-mediated knockdown of cyp26a1, cyp26b1 and cyp26c1
in zebrafish (Echeverri and Oates,
2007
; Hernandez et al.,
2007
; Kudoh et al.,
2002
; Reijntjes et al.,
2007
; Shelton et al.,
2006
; White et al.,
2007
). Of the zebrafish reports, only one addressed the role of
Cyp26 enzymes during skeletogenesis, claiming that Cyp26b1 is required for the
patterning and migration of cranial neural crest
(Reijntjes et al., 2007
).
Knockout of Cyp26b1 in mouse causes severe limb defects that have
been attributed to a combination of shifts in the proximodistal patterning of
the limb bud and a retardation of chondrocyte maturation
(Yashiro et al., 2004
). This
suggests that Cyp26b1 interferes with the reported role of RA in blocking
chondrocyte specification from mesenchymal precursors
(Weston et al., 2003
). Other
data suggest a later and seemingly opposing role for RA signaling in promoting
hypertrophic maturation of chondrocytes and subsequent replacement by bone
(Weston et al., 2003
),
although this has not yet been addressed genetically. Also, it has remained
unclear to what extent this latter effect is due to interference with
chondrocytes (Iwamoto et al.,
1993
; Weston et al.,
2003
) versus osteoblasts
(Manji et al., 1998
;
Song et al., 2005
) and with
osteoblast maturation versus activity.
Here, we have studied the role of Cyp26b1 as an essential regulator of
skeletal development in zebrafish. cyp26b1 is expressed in
chondrogenic mesenchymal condensations as well as in osteoblast precursors of
endochondral and intramembranous bones, including vertebrae. cyp26b1
mutants display multiple defects during chondro- and osteogenesis, all of
which can be mimicked by treatment with RA. This indicates that in contrast to
a recent report (Reijntjes et al.,
2007
), zebrafish Cyp26b1 acts by restricting retinoid signaling.
The hyperossification of craniofacial bones and vertebrae of mutant animals is
anticipated by an increase in osteopontin expression in osteoblasts.
Comparing the axial defects of cyp26b1 mutants with those caused by
transgenic overexpression of the Bone morphogenetic protein Bmp2, a well-known
positive regulator of osteoblast maturation upstream of Runx2 and Osx
(Ulsamer et al., 2008
;
Wu et al., 2007
), we noticed
striking differences in the pattern of hyperossification and in the molecular
signature of the supernumerary osteoblasts. Together, these data suggest that
RA inhibition by Cyp26 enzymes is required to restrict ossification in vivo,
most likely by attenuating osteoblast activity.
| MATERIALS AND METHODS |
|---|
|
|
|---|
24
hours.
Mapping and cloning of dol/cyp26b1
Genetic rough mapping of dolti230g was carried out via
bulk meiotic segregation analyses as described
(Laue et al., 2008
). For
chromosomal walking, the BAC libraries CHORI-211 and DanioKey (RZPD) were
screened by PCR. For identification of the mutant lesion and for genotyping,
genomic cyp26b1 DNA or cDNA (GenBank accession number AY321366)
fragments were amplified by PCR and sequenced. Primer sequences are available
upon request.
Morpholino oligonucleotide (MO) injections
An MO against the cyp26b1 splice-donor junction between exon 3 and
intron 3 (Cyp26b1-SDEx3 MO, 5'-AGCTATTGACATTTTACCTTTCTGT-3') was
purchased from Gene Tools. For full knockdown,
0.5 pmol, and for
hypomorphs (Fig. 6E), 0.2 pmol,
of MO was injected per embryo at the one-cell stage as described
(Nasevicius and Ekker, 2000
).
aldh1a MO was used as described
(Begemann et al., 2001
).
Tissue labeling procedures
In situ hybridization and fluorescent double in situ hybridization were
performed as described (Clay and
Ramakrishnan, 2005
;
Hammerschmidt et al., 1996
).
For zebrafish opn and osx, cDNA fragments were amplified by
RT-PCR with primer sequences obtained from the Ensembl database, and cloned
into pCRII-TOPO (Invitrogen). For probe synthesis, plasmids were linearized
with XhoI and transcribed with SP6 RNA polymerase. For
cyp26b1, clone IMAGp998A0411194Q1 was obtained from RZPD, linearized
with KpnI and transcribed with SP6 RNA polymerase. Probes for
cyp26a1 and cyp26c1
(Hernandez et al., 2007
),
col2a1 (Yan et al.,
1995
), col10a1 (Nica
et al., 2006
), dlx2a
(Akimenko et al., 1994
) and
sox9a (Wada et al.,
2005
) were synthesized as described.
Immunostainings were carried out using the Vectastain ABC Kit (Axxora) with the following primary antibodies and dilutions: zn5 (1:500, ZIRC, University of Oregon), anti-GFP (1:200, Roche). For sectioning, embryos were embedded in paraffin.
Skeletal elements of zebrafish and mice were stained with Alcian Blue
and/or Alizarin Red essentially as described
(Kessel and Gruss, 1991
;
Walker and Kimmel, 2007
).
Drug treatments
Stock solutions (10 mM) of 4-(diethylamino)benzaldehyde (DEAB; Fluka),
all-trans RA (Sigma) and R115866 (Johnson and Johnson Pharmaceutical Research
and Development) were prepared in DMSO as described
(Begemann et al., 2004
;
Begemann et al., 2001
;
Hernandez et al., 2007
).
Wild-type or cyp26b1 mutant zebrafish were incubated in the dark with
final concentrations of 0.5 µM RA (before 50 hpf), 10 µM RA (after 48
hpf), 10 µM DEAB (before 50 hpf), 50 µM DEAB (after 48 hpf) or 10 µM
R115866. For mouse experiments, R115866 was dissolved in PEG 200 (Sigma, 2.5
mg/ml) and administered to pregnant NMRI females by daily oral gavages,
applying 10 mg per kilogram body weight, from E13-16.
| RESULTS |
|---|
|
|
|---|
The three BACs contained several genes, all of which were sequenced. Only
in the cyp26b1 gene of mutants was a mutation found, comprising a
GT
AT transition in the splice-donor site of the exon 3-intron 3 junction
(Fig. 1H,I). Sequencing of
independent cDNA clones revealed the use of a downstream GT as a novel
splice-donor in mutants (50/50), but not in wild-type embryos of the same
strain (0/50) (Fig. 1I,J). The
resulting transcript carries an insertion of seven nucleotides, leading to a
frame shift and premature termination of the protein. This C-terminal
truncation removes most of the highly conserved cytochrome P450 domain,
including the oxygen-, steroid- and heme-binding sites
(Fig. 1G). Subsequently, a
second cyp26b1 allele, sa0002, was identified by TILLING
(Wienholds et al., 2003
), with
an AAG
TAG nonsense mutation at nucleotide position 135 of the coding
region, causing an even more severe truncation of the protein after 45 amino
acid residues (Fig. 1G)
(http://www.sanger.ac.uk/cgi-bin/Projects/D_rerio/mutres/tracking.pl).
sa0002 failed to complement ti230g, and sa0002
mutants showed craniofacial and axial defects indistinguishable from those of
ti230g mutants (see Fig. S1A-C,E-G in the supplementary material). In
contrast to full-length Cyp26b1, both truncated versions were completely
inactive upon forced expression in early zebrafish embryos (see Fig. S1I-L in
the supplementary material). Furthermore, the axial hyperossification of
ti230g mutants could be rescued or converted to hypo-ossified
phenotypes by temporally controlled reapplication of wild-type
cyp26b1 (see Fig. S1H in the supplementary material). Finally, the
defects of dol mutants could be phenocopied in wild-type fish by
injecting an antisense MO targeting the splice site affected in the
ti230g allele (Fig.
4G,N; Fig. 5C;
Fig. 6E,F; see Fig. S2 in the
supplementary material). Together, this indicates that the defects of
zebrafish dol mutants are caused by null mutations in the
cyp26b1 gene.
|
At 48 hpf, cyp26b1 was coexpressed with sox9a
(Fig. 2H) in mesenchymal
condensations that give rise to pharyngeal arches
(Fig. 2F) and neurocranial
cartilages (Fig. 2G). However,
concomitant with the onset of col2a1 expression, which is a marker
for specified chondrocytes (Yan et al.,
1995
), cyp26b1 expression ceased within the cartilaginous
elements but remained strong in perichondrial cells
(Fig. 2I-K). A similar
transient expression in mesenchymal condensations and persistent expression in
perichondria of the craniofacial skeletal elements has also been described for
mouse Cyp26b1 (Abu-Abed et al.,
2002
). The perichondrium is a supposed source of osteoblasts.
However, in contrast to widespread perichondrial expression of
cyp26b1, expression of the osteoblast markers osterix
(osx) (Fig. 2L),
osteopontin (opn) (Fig.
2M) and col10a1 (Fig.
2N) (Avaron et al.,
2006
) was confined to those perichondrial domains undergoing
endochondral ossification (Fig.
2O). In such col10a1-positive cells, cyp26b1
transcript levels were lower than in the adjacent col10a1-negative
perichondrium (Fig. 2P,Q),
suggesting that cyp26b1 expression decreases when osteoblasts
differentiate and/or become active.
In addition to the perichondrium/periosteum, zebrafish cyp26b1 was
expressed in various bone primordia that ossify in an intramembranous manner
(Cubbage and Mabee, 1996
;
Elizondo et al., 2005
).
Examples include the opercle (Fig.
3A,D) and cleithrum (see Fig. S4G in the supplementary material).
At 72 and 120 hpf, the opercular bone matrix
(Fig. 3C,F) was surrounded by
osteoblasts coexpressing col10a1, osx and opn
(Fig. 3B,E; see S4A-F in the
supplementary material). Double in situ hybridization for cyp26b1 and
col10a1 further revealed that, similar to in the perichondrium,
cyp26b1 levels in col10a1-positive osteoblasts of the
opercle (Fig. 3A,D) and
cleithrum (see Fig. S4G in the supplementary material) were considerably
weaker than in adjacent cells, which are most likely immature and/or less
active osteoblasts.
Osteoblast expression of cyp26b1 was also found in the elements of the axial skeleton. The anterior part of the notochord, which becomes uniformly ossified (basioccipital articulatory process) (see Fig. 6A), was lined by a continuous layer of cyp26b1-positive cells (Fig. 3G), whereas in trunk and tail, where ossification of vertebral primordia occurs in a segmented manner, cyp26b1-positive cells displayed a corresponding metameric distribution (Fig. 3H,I). The same metameric pattern was obtained for the osteoblast markers opn and col10a1 (Fig. 3L-N). The position of such osteoblasts at intersomitic borders coincided with the anterior borders of forming vertebral bodies stained with Alizarin Red (Fig. 3O), suggesting that cells were localized within the intervertebral zones. Comparative expression analyses at different developmental time points further revealed a continuous decline in the number of axial cyp26b1-positive cells from 96-156 hpf, while the number of col10a1- and opn-positive cells increased (Fig. 3P), with transient coexpression of cyp26b1 and opn in the same cells at 144 hpf (Fig. 3J).
|
cyp26b1 mutants display hyperossification of craniofacial bones and axial skeleton, leading to the fusion of vertebral bodies
As in higher vertebrates, the majority of the zebrafish craniofacial
skeleton forms through endochondral ossification, starting at 6 days
post-fertilization (dpf); for example, in restricted regions of the ceratohyal
and hyomandibula of the second pharyngeal arch. Intramembranous bones form
even earlier, with mineralization of the opercle starting at 3 dpf
(Cubbage and Mabee, 1996
).
|
In addition to craniofacial defects, cyp26b1 mutants and morphants
exhibited severe abnormalities in the axial skeleton, which in teleost larvae
is formed through ossification of the sheath around the notochord (perichordal
ossification). In zebrafish, unsegmented ossification around the anterior part
of the notochord gives rise to the basioccipital articulatory process, while
metameric mineralization more posteriorly forms the vertebral column.
Vertebral ossification starts at the level of the fourth vertebral body
(centrum), from where it proceeds anteriorly and posteriorly
(Bird and Mabee, 2003
;
Gavaia et al., 2006
;
Stemple, 2005
). At 180 hpf,
wild-type larvae exhibited six to eight Alizarin Red-positive centra, with
centra 3 and 4 correspondingly broader than the others
(Fig. 6A). By contrast,
cyp26b1 mutants and morphants showed a complete fusion of Alizarin
Red-positive segments and an extension of staining into caudal regions, which
in wild-type animals mineralize later (Du
et al., 2001
) (Fig.
6C,F). In cross-sections, the mineralized perichordal sheath of
mutants appeared broader and more strongly stained than in wild-type siblings,
whereas notochordal cells remained Alizarin Red-negative and normally
vacuolated (Fig. 6G-J).
Interestingly, cyp26b1 heterozygotes and wild-type embryos injected
with lower amounts of cyp26b1 MO displayed an intermediate phenotype
with distinct, but broader, centra in anterior regions and precocious centra
mineralization in caudal regions of the notochord
(Fig. 6, compare B,E with A,D).
This suggests that Cyp26b1 is required to attenuate vertebral growth.
|
|
Strikingly, RA treatment of wild-type embryos from 24 to 50 hpf caused the
same neurocranial phenotype as in cyp26b1 mutant embryos,
characterized by the absence of the medial ethmoid plate at 120 hpf
(Fig. 7A,B; compare with
Fig. 4M) (n=25/25). By
contrast, RA treatments commencing after 48 hpf did not alter anterior
neurocranial morphology (data not shown). Conversely, DEAB treatment of
cyp26b1 mutants and morphants from 24 to 50 hpf rescued the ethmoid
phenotype (Fig. 7D)
(n=9/10), whereas the same treatment of wild-type embryos left
neurocranial morphology intact (Fig.
7C) (n=29/29) but caused a reduction of gill arches,
reminiscent of the phenotype of aldh1a mutants
(Begemann et al., 2001
).
Together, this indicates that the anterior neurocranial cartilage defects of
cyp26b1 mutants are caused by RA excess during the second day of
development.
|
The temporal and spatial pattern of axial hyperossification caused by RA differs from that caused by Bmp2b
To gain insight into the cellular basis of RA-induced hyperossification, we
compared the effects of RA application with those caused by excessive Bmp2, a
well-known positive regulator of osteoblast maturation
(Wu et al., 2007
). For
temporally controlled Bmp2 overexpression, we used transgenic fish that carry
the bmp2b cDNA under the control of the heat-inducible hsp70
promoter (Chocron et al.,
2007
). Applying the heat shock at 50 hpf, when RA applications had
no effect on centra ossification (Fig.
7J), transgenic bmp2b fish displayed a fusion of centra
3-6 (Fig. 7O). These are the
first ossifying centra during normal development (see above). By contrast,
Bmp2 applied at 96 or 144 hpf left the early-ossifying centra unaffected,
causing fusions of the later ossifying, more-anterior and more-posterior
vertebral bodies (Fig. 7P)
(data not shown), whereas centra 3-6 were fused upon RA application at these
later stages (Fig. 7K; see Fig.
S6A,B in the supplementary material). Strikingly, fusions of centra 3-6 were
even obtained upon RA administration at 12 or 15 dpf
(Fig. 7M,N; see Fig. S6C-F in
the supplementary material). This indicates that Bmp2 affects osteoblast
precursors at stages when they are not yet sensitive to RA, whereas RA can
still affect osteoblasts long after they have become insensitive to Bmp2.
cyp26b1 mutant osteoblasts display increased expression of osteopontin
To directly compare the effects of Cyp26b1/RA and Bmp2b on osteoblasts, we
stained for the osteoblast markers col10a1, osx, opn and
cyp26b1 itself. In craniofacial skeletal elements of cyp26b1
mutants, cyp26b1 expression was much stronger than in wild-type
siblings (Fig. 8A). Similarly,
osteoblasts of the opercle of mutants displayed stronger opn
expression. At 72 hpf, the number of opn-positive cells appeared
normal, with higher expression levels per cell
(Fig. 8B). However, at 120 hpf,
there were supernumerary cells in normally opn-negative subdomains of
the opercle (Fig. 8C). By
contrast, expression levels and patterns of osx and col10a1
appeared unaltered in mutants (Fig.
8D,E).
Similarly, in the axial skeleton, cyp26b1 mutants displayed a
striking increase in cyp26b1- and opn-positive cells, with
premature expression and an extension into more-posterior trunk regions
(Fig. 8F,G; see Fig. S7 in the
supplementary material), whereas the number of col10a1-positive cells
was normal (Fig. 8H). Ectopic
cyp26b1-positive cells were present ventral of the notochord, in
contrast to their preferential perichordal localization in wild-type siblings
(Fig. 8F). According to
previous studies, axial osteoblasts stem from the sclerotome in ventral-most
regions of the somites, from where they move dorsally towards the notochord
(Inohaya et al., 2007
;
Morin-Kensicki and Eisen,
1997
), consistent with the ventral-to-dorsal progression of centra
ossification (Fig. 6K). Thus,
the ventral cyp26b1-positive cells are possibly immature osteoblasts
that express cyp26b1 precociously in the mutant.
|
Cyp26 feedback loop, as described previously in other
circumstances (Emoto et al.,
2005
Inhibition of Cyp26 enzymes during mouse development leads to axial hyperossification and to fusion of cervical vertebrae
To study whether Cyp26 enzymes might have a similar role in restricting
ossification during mammalian development, we treated mouse fetuses with the
Cyp26 inhibitor R115866, starting at E13, shortly before the onset of
vertebral ossification in untreated animals. At E18.5, treated mice often
displayed fusions of neural arches of cervical vertebrae, particularly in
C3-C5 (Fig. 9A,B)
(n=4). However, no fusions were seen in thoracic, sacral or lumbar
vertebrae, similar to the cervical restriction of fusions that is seen in
several human vertebral disorders. Instead, in posterior regions, treated mice
displayed ossification defects within vertebrae, including precocious fusions
of neural arches with centra (Fig.
9C,D) (n=9). Also, the ribs were significantly thicker
than in untreated embryos. In summary, this indicates that inhibition of
Cyp26b1 causes similar shifts in the temporal and spatial pattern of
ossification in mammals as in zebrafish.
| DISCUSSION |
|---|
|
|
|---|
|
|
Cyp26b1-dependent RA restriction is required for proper spatiotemporal control of osteoblast biology and bone formation
In Cyp26b1 mutant mice, possible defects during bone formation
have only been marginally addressed
(Yashiro et al., 2004
). Also,
expression of mouse Cyp26b1 in osteoblasts has not been described
(Abu-Abed et al., 2002
). Here,
we show that zebrafish cyp26b1 transcripts colocalize at least
transiently with osx, col10a1 and opn, even in developing
intramembranous bones that lack chondrocytes, strongly suggesting that
cyp26b1 is expressed in osteoblasts. Our analyses further indicate
that cyp26b1 expression levels are particularly high in immature
and/or less active osteoblasts, whereas expression in fully differentiated
and/or highly active osteoblasts is much lower, in line with its proposed role
in attenuating osteoblast maturation and/or activity. In cell culture systems,
RA has also been shown to promote hypertrophic maturation/activity of
chondrocytes (Weston et al.,
2003
). Whether a similar mechanism contributes to the
hyperossification of endochondral bones in zebrafish cyp26b1 mutants
remains unclear. However, this seems unlikely because cyp26b1 is only
transiently expressed in chondrocytes and is switched off as they specify
(Fig. 2).
In addition to endochondral bones, cyp26b1 mutants display
hyperossification of intramembranous bones, which leads to overgrowth of the
elements (Figs 5 and
6). In the vertebral column,
this results in a complete fusion of centra
(Fig. 6), whereas the opposite
phenotype, complete loss of vertebral ossification, is obtained upon
cyp26b1 overexpression (see Fig. S1H in the supplementary material).
Vertebral fusions in cyp26b1 mutants manifest rather late, and cannot
be due to shifts in vertebral identities because somitic expression of all
tested Hox genes (hoxc6b, hoxc8a, hoxb8b, hoxb10a)
(Prince et al., 1998
) is
unaffected at 24 hpf and later (our unpublished observations).
Our in situ hybridization analysis further revealed a precocious initiation
of expression and a significant increase in the number of cyp26b1-
and opn-positive cells in cyp26b1 mutants
(Fig. 8; see Fig. S7 in the
supplementary material). The precocious expression in ectopic positions could
be interpreted as a consequence of premature osteoblast maturation. However,
several lines of evidence suggest that in addition to maturation, or even
instead of it, RA affects osteoblast activity. First, cyp26b1 mutants
displayed a striking increase in opn transcript levels per cell,
which, at least in the opercle, clearly preceded the increase in cell numbers.
In osteoblast cell cultures, opn levels are often used to measure
osteoblast activity because they increase in proportion to the amount of
mineralized bone material, also in response to RA
(Manji et al., 1998
;
Ohishi et al., 1995
;
Song et al., 2005
). Second,
cyp261 mutants displayed normal numbers of cells expressing other
osteoblast markers, col10a1 and osx. This is in striking
contrast to the effect of Bmp2 overexpression, a well-studied positive
regulator of osteoblast maturation, which caused hyperossification accompanied
by an increase of col10a1-positive cells (Figs
7 and
8). Finally, axial osteoblasts
were still sensitive to RA many days after they had arrived at their final
perichordal destination and after they had become insensitive to Bmp2 (15
versus 4 dpf) (compare Fig. 7N
with Fig. 3H and
Fig. 7P).
In cell culture studies, RA and Bmp2 have also been shown to stimulate
osteoclasts, which are bone-resorbing cells of the hematopoietic lineage
(Cowan et al., 2005
;
Kaji et al., 1995
). However,
for several reasons, this does not seem relevant for the ossification defects
of cyp26b1 mutants. First, we would expect a stimulation of
osteoclasts to result in loss, rather than the observed gain, of bone. Second,
according to histological stainings of the osteoclast marker enzyme
tartrate-resistant acid phosphatase (TRAP; Acp5 - ZFIN), osteoclasts only
become active long after the bone phenotype of cyp26b1 mutants has
become apparent (14 dpf) (Gavaia et al.,
2006
; Witten et al.,
2001
). Third, knockdown of pu.1 (Spi1 - ZFIN), which is
required for specification of the entire myeloid lineage including osteoclasts
(Rhodes et al., 2005
;
Zhao et al., 2007
), did not
affect axial ossification, although other myeloid derivatives, such as
mpx-positive neutrophils, were completely absent (our unpublished
results). This suggests that in contrast to Cyp26b1 and osteoblasts,
osteoclasts are dispensable for bone formation during the larval stages we
have investigated.
Cyp26b1 and human disease: is dolphin a model for Klippel-Feil anomaly (KFA) or related syndromes?
In higher vertebrates, such as birds and mammals, vertebra formation occurs
via endochondral ossification, whereas in teleosts, vertebral bodies are
formed through direct ossification in and around the notochordal sheath
(perichordal centra). There has been some debate about the involvement of
osteoblasts in fish axial skeleton development. According to one report,
vertebral bodies in zebrafish arise by secretion of bone matrix from the
notochord and without any involvement of osteoblasts
(Fleming et al., 2004
). By
contrast, a more recent report claims that sclerotome-derived osteoblasts are
present in intervertebral regions in Medaka
(Inohaya et al., 2007
). Our
data are consistent with the latter report and with the situation in higher
vertebrates, pointing to the presence and activity of osteoblasts during
vertebral ossification in zebrafish. In addition, our data indicate that the
role of Cyp26 enzymes in preventing hyperossification and vertebrae fusions
has been largely conserved between fish and mammals. Mouse Cyp26b1
displays metameric expression in the developing vertebral column
(Abu-Abed et al., 2002
), which
could correspond to the cyp26b1 expression in intervertebral regions
described here. Cyp26b1 mouse mutants have been reported to display a
fusion of the two first cervical vertebrae, atlas and axis (G. A. MacLean, PhD
thesis, Queen's University Kingston, Ontario, Canada, 2007;
http://hdl.handle.net/1974/750).
It had been proposed that this fusion is due to RA-induced homeotic
transformations in vertebral anterior-posterior (AP) identity. However, we
show here that inhibition of Cyp26 activity leads to hyperossifications and to
fusions of cervical vertebrae when the drug is applied days after vertebral AP
identity has been determined (E9-11)
(Kessel, 1992
;
Kessel and Gruss, 1991
). This
suggests that, as in zebrafish, mouse Cyp26 enzymes are required to regulate
ossification.
In humans, several disorders with cervical vertebral fusions have been
described. A rather common (1:40,000) congenital disorder with such fusions is
Klippel-Feil anomaly (KFA; OMIM 118100)
(Kaplan et al., 2005
;
Tracy et al., 2004
). KFA
occurs sporadically, as well as in families with dominant or recessive
inheritance. Its aetiology is unknown. Vertebral fusion is variably associated
with craniofacial abnormalities, including frontonasal dysplasia, and various
limb malformations. A similar association of vertebral and other developmental
defects is observed in Goldenhar syndrome (OMIM 164210), MURCS association
(OMIM 601076) and VATER association (OMIM 192350).
Zebrafish cyp26b1 mutants display a reduction in the anterior
neurocranium and compromised pectoral fin development, consistent with
frontonasal and limb abnormalities seen in some of the human syndromes.
Homozygous null mutants die during late larval stages (10-15 dpf); however,
hypomorphic alleles are sub-viable and characterized by progressive vertebral
defects (Spoorendonk et al.,
2008
). Similar mutations could account for recessively inherited
cases of human KFA, whereas the sporadic or dominantly inherited cases could
be due to haploinsufficiencies of null mutations, as described here for the
zebrafish ti230g allele, or to antimorphic mutations.
Interestingly, a sporadic case of KFA associated with craniofacial and ear
defects has been correlated with an inversion on chromosome 2(p12q34)
(Papagrigorakis et al., 2003
).
The human CYP26B1 gene is located at 2p13, close to this breakpoint.
In collaboration with human geneticists, we are currently readdressing this
case, and are sequencing CYP26B1 from other subjects with diagnosed
KFA or Goldenhar syndrome (McGaughran et
al., 2003
).
Supplementary material
Supplementary material for this article is available at
http://dev.biologists.org/cgi/content/full/135/22/3775/DC1
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
| REFERENCES |
|---|
|
|
|---|
Abu-Abed, S., Dolle, P., Metzger, D., Beckett, B., Chambon, P.
and Petkovich, M. (2001). The retinoic acid-metabolizing
enzyme, CYP26A1, is essential for normal hindbrain patterning, vertebral
identity, and development of posterior structures. Genes
Dev. 15,226
-240.
Abu-Abed, S., MacLean, G., Fraulob, V., Chambon, P., Petkovich,
M. and Dolle, P. (2002). Differential expression of the
retinoic acid-metabolizing enzymes CYP26A1 and CYP26B1 during murine
organogenesis. Mech. Dev.
110,173
-177.[CrossRef][Medline]
Adams, S. L., Cohen, A. J. and Lassova, L.
(2007). Integration of signaling pathways regulating chondrocyte
differentiation during endochondral bone formation. J. Cell
Physiol. 213,635
-641.[CrossRef][Medline]
Akimenko, M.-A., Ekker, M., Wegner, J., Lin, W. and Westerfield,
M. (1994). Combinatorial expression of three zebrafish genes
related to distal-less: part of a homeobox gene code for the head.
J. Neurosci. 16,3475
-3486.
Alford, A. I. and Hankenson, K. D. (2006).
Matricellular proteins: extracellular modulators of bone development,
remodeling, and regeneration. Bone
38,749
-757.[CrossRef][Medline]
Avaron, F., Hoffman, L., Guay, D. and Akimenko, M. A.
(2006). Characterization of two new zebrafish members of the
Hedgehog family: atypical expression of a zebrafish indian hedgehog
gene in skeletal elements of both endochondral and dermal origins.
Dev. Dyn. 235,478
-489.[CrossRef][Medline]
Begemann, G., Schilling, T. F., Rauch, G. J., Geisler, R. and
Ingham, P. W. (2001). The zebrafish neckless mutation reveals
a requirement for raldh2 in mesodermal signals that pattern the hindbrain.
Development 128,3081
-3094.
Begemann, G., Marx, M., Mebus, K., Meyer, A. and Bastmeyer,
M. (2004). Beyond the neckless phenotype: influence of
reduced retinoic acid signaling on motor neuron development in the zebrafish
hindbrain. Dev. Biol.
271,119
-129.[CrossRef][Medline]
Bird, N. C. and Mabee, P. M. (2003).
Developmental morphology of the axial skeleton of the zebrafish, Danio rerio
(Ostariophysi: Cyprinidae). Dev. Dyn.
228,337
-357.[CrossRef][Medline]
Blomhoff, R. and Blomhoff, H. K. (2006).
Overview of retinoid metabolism and function. J.
Neurobiol. 66,606
-630.[CrossRef][Medline]
Chocron, S., Verhoeven, M. C., Rentzsch, F., Hammerschmidt, M.
and Bakkers, J. (2007). Zebrafish Bmp4 regulates left-right
asymmetry at two distinct developmental time points. Dev.
Biol. 305,577
-588.[CrossRef][Medline]
Clay, H. and Ramakrishnan, L. (2005). Multiplex
fluorescent in situ hybridization in zebrafish embryos using tyramide signal
amplification. Zebrafish
2, 105-111.[CrossRef][Medline]
Colnot, C. (2005). Cellular and molecular
interactions regulating skeletogenesis. J. Cell.
Biochem. 95,688
-697.[CrossRef][Medline]
Cowan, C. M., Aalami, O. O., Shi, Y. Y., Chou, Y. F., Mari, C.,
Thomas, R., Quarto, N., Nacamuli, R. P., Contag, C. H., Wu, B. et al.
(2005). Bone morphogenetic protein 2 and retinoic acid accelerate
in vivo bone formation, osteoclast recruitment, and bone turnover.
Tissue Eng. 11,645
-658.[CrossRef][Medline]
Cubbage, C. C. and Mabee, P. M. (1996).
Developmental morphology of the axial skeleton of the zebrafish, Danio rerio
(ostariophysi: Cyprinidae). J. Morphol.
129,121
-160.
Du, S. J., Frenkel, V., Kindschi, G. and Zohar, Y.
(2001). Visualizing normal and defective bone development in
zebrafish embryos using the fluorescent chromophore calcein. Dev.
Biol. 238,239
-246.[CrossRef][Medline]
Eberhart, J. K., Swartz, M. E., Crump, J. G. and Kimmel, C.
B. (2006). Early hedgehog signaling from neural to oral
epithelium organizes anterior craniofacial development.
Development 133,1069
-1077.
Echeverri, K. and Oates, A. C. (2007).
Coordination of symmetric cyclic gene expression during somitogenesis by
Suppressor of Hairless involves regulation of retinoic acid catabolism.
Dev. Biol. 301,388
-403.[CrossRef][Medline]
Elizondo, M. R., Arduini, B. L., Paulsen, J., MacDonald, E. L.,
Sabel, J. L., Henion, P. D., Cornell, R. A. and Parichy, D. M.
(2005). Defective skeletogenesis with kidney stone formation in
dwarf zebrafish mutant for trpm7. Curr. Biol.
15,667
-671.[CrossRef][Medline]
Emoto, Y., Wada, H., Okamoto, H., Kudo, A. and Imai, Y.
(2005). Retinoic acid-metabolizing enzyme Cyp26a1 is essential
for determining territories of hindbrain and spinal cord in zebrafish.
Dev. Biol. 278,415
-427.[CrossRef][Medline]
Fleming, A., Keynes, R. and Tannahill, D.
(2004). A central role for the notochord in vertebral patterning.
Development 131,873
-880.
Flores, M. V., Tsang, K. W. K., Hu, W., Kalev-Zylinska, M.,
Postlethwait, J., Crosier, P., Crosier, K. and Fisher, S.
(2004). Duplicate zebrafish runx2 orthologues are expressed in
developing skeletal elements. Gene Expr. Patterns
4, 573-581.[CrossRef][Medline]
Flores, M. V., Lam, E. Y., Crosier, P. and Crosier, K.
(2006). A hierarchy of Runx transcription factors modulate the
onset of chondrogenesis in craniofacial endochondral bones in zebrafish.
Dev. Dyn. 235,3166
-3176.[CrossRef][Medline]
Fujii, H., Sato, T., Kaneko, S., Gotoh, O., Fujii-Kuriyama, Y.,
Osawa, K., Kato, S. and Hamada, H. (1997). Metabolic
inactivation of retinoic acid by a novel P450 differentially expressed in
developing mouse embryos. EMBO J.
16,4163
-4173.[CrossRef][Medline]
Gavaia, P. J., Simes, D. C., Ortiz-Delgado, J. B., Viegas, C.
S., Pinto, J. P., Kelsh, R. N., Sarasquete, M. C. and Cancela, M. L.
(2006). Osteocalcin and matrix Gla protein in zebrafish (Danio
rerio) and Senegal sole (Solea senegalensis): comparative gene and protein
expression during larval development through adulthood. Gene Expr.
Patterns 6,637
-652.[CrossRef][Medline]
Gu, X., Xu, F., Wang, X., Gao, X. and Zhao, Q.
(2005). Molecular cloning and expression of a novel CYP26 gene
(cyp26d1) during zebrafish early development. Gene Expr.
Patterns 5,733
-739.[CrossRef][Medline]
Hammerschmidt, M., Pelegri, F., Mullins, M. C., Kane, D. A., van
Eeden, F. J. M., Granato, M., Brand, M., Furutani-Seiki, M., Haffter, P.,
Heisenberg, C.-P. et al. (1996). dino and
mercedes, two genes regulating dorsal development in the zebrafish
embryo. Development 123,95
-102.[Abstract]
Hernandez, R. E., Putzke, A. P., Myers, J. P., Margaretha, L.
and Moens, C. B. (2007). Cyp26 enzymes generate the retinoic
acid response pattern necessary for hindbrain development.
Development 134,177
-187.
Inohaya, K., Takano, Y. and Kudo, A. (2007).
The teleost intervertebral region acts as a growth center of the centrum:
in vivo visualization of osteoblasts and their progenitors in
transgenic fish. Dev. Dyn.
236,3031
-3046.[CrossRef][Medline]
Isogai, S., Lawson, N. D., Torrealday, S., Horiguchi, M. and
Weinstein, B. M. (2003). Angiogenic network formation in the
developing vertebrate trunk. Development
130,5281
-5290.
Iwamoto, M., Golden, E. B., Adams, S. L., Noji, S. and Pacifici,
M. (1993). Responsiveness to retinoic acid changes during
chondrocyte maturation. Exp. Cell Res.
205,213
-224.[CrossRef][Medline]
Kaji, H., Sugimoto, T., Kanatani, M., Fukase, M., Kumegawa, M.
and Chihara, K. (1995). Retinoic acid induces osteoclast-like
cell formation by directly acting on hemopoietic blast cells and stimulates
osteopontin mRNA expression in isolated osteoclasts. Life
Sci. 56,1903
-1913.[CrossRef][Medline]
Kaplan, K. M., Spivak, J. M. and Bendo, J. A.
(2005). Embryology of the spine and associated congenital
abnormalities. Spine J.
5, 564-576.[CrossRef][Medline]
Karsenty, G. and Wagner, E. F. (2002). Reaching
a genetic and molecular understanding of skeletal development. Dev.
Cell 2,389
-406.[CrossRef][Medline]
Kawasaki, K., Suzuki, T. and Weiss, K. M.
(2004). Genetic basis for the evolution of vertebrate mineralized
tissues. Proc. Natl. Acad. Sci. USA
101,11356
-11361.
Kessel, M. (1992). Respecification of vertebral
identities by retinoic acid. Development
115,487
-501.[Abstract]
Kessel, M. and Gruss, P. (1991). Homeotic
transformations of murine vertebrae and concomitant alteration of Hox codes
induced by retinoic acid. Cell
67, 89-104.[CrossRef][Medline]
Kimmel, C. B., Ullmann, B., Walker, M., Miller, C. T. and Crump,
J. G. (2003). Endothelin 1-mediated regulation of pharyngeal
bone development in zebrafish. Development
130,1339
-1351.
Kudoh, T., Wilson, S. W. and Dawid, I. B.
(2002). Distinct roles for Fgf, Wnt and retinoic acid in
posteriorizing the neural ectoderm. Development
129,4335
-4346.[Medline]
Lammer, E. J., Chen, D. T., Hoar, R. M., Agnish, N. D., Benke,
P. J., Braun, J. T., Curry, C. J., Fernhoff, P. M., Grix, A. W., Jr, Lott, I.
T. et al. (1985). Retinoic acid embryopathy. N.
Engl. J. Med. 313,837
-841.[Abstract]
Laue, K., Daujat, S., Crump, J. G., Plaster, N., Roehl, H. H.,
Kimmel, C. B., Schneider, R. and Hammerschmidt, M. (2008).
The multidomain protein Brpf1 binds histones and is required for Hox gene
expression and segmental identity. Development
135,1935
-1946.
MacLean, G., Abu-Abed, S., Dolle, P., Tahayato, A., Chambon, P.
and Petkovich, M. (2001). Cloning of a novel retinoic-acid
metabolizing cytochrome P450, Cyp26B1, and comparative expression analysis
with Cyp26A1 during early murine development. Mech.
Dev. 107,195
-201.[CrossRef][Medline]
MacLean, G., Li, H., Metzger, D., Chambon, P. and Petkovich,
M. (2007). Apoptotic extinction of germ cells in testes of
Cyp26b1 knockout mice. Endocrinology
148,4560
-4567.
Manji, S. S., Ng, K. W., Martin, T. J. and Zhou, H.
(1998). Transcriptional and posttranscriptional regulation of
osteopontin gene expression in preosteoblasts by retinoic acid. J.
Cell Physiol. 176,1
-9.[CrossRef][Medline]
Mariani, F. V. and Martin, G. R. (2003).
Deciphering skeletal patterning: clues from the limb.
Nature 423,319
-325.[CrossRef][Medline]
McGaughran, J. M., Oates, A., Donnai, D., Read, A. P. and
Tassabehji, M. (2003). Mutations in PAX1 may be associated
with Klippel-Feil syndrome. Eur. J. Hum. Genet.
11,468
-474.[CrossRef][Medline]
Morin-Kensicki, E. M. and Eisen, J. S. (1997).
Sclerotome development and peripheral nervous system segmentation in embryonic
zebrafish. Development
124,159
-167.[Abstract]
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M.,
Behringer, R. R. and de Crombrugghe, B. (2002). The novel
zinc finger-containing transcription factor osterix is required for osteoblast
differentiation and bone formation. Cell
108, 17-29.[CrossRef][Medline]
Nasevicius, A. and Ekker, S. C. (2000).
Effective targeted gene `knockdown' in zebrafish. Nat.
Genet. 26,216
-220.[CrossRef][Medline]
Nica, G., Herzog, W., Sonntag, C., Nowak, M., Schwarz, H.,
Zapata, A. G. and Hammerschmidt, M. (2006). Eya1 is required
for lineage-specific differentiation, but not for cell survival in the
zebrafish adenohypophysis. Dev. Biol.
292,189
-204.[CrossRef][Medline]
Niederreither, K. and Dolle, P. (2008).
Retinoic acid in development: towards an integrated view. Nat. Rev.
Genet. 9,541
-553.[CrossRef][Medline]
Niederreither, K., Abu-Abed, S., Schuhbaur, B., Petkovich, M.,
Chambon, P. and Dolle, P. (2002). Genetic evidence that
oxidative derivatives of retinoic acid are not involved in retinoid signaling
during mouse development. Nat. Genet.
31, 84-88.[Medline]
Njar, V. C., Gediya, L., Purushottamachar, P., Chopra, P.,
Vasaitis, T. S., Khandelwal, A., Mehta, J., Huynh, C., Belosay, A. and Patel,
J. (2006). Retinoic acid metabolism blocking agents (RAMBAs)
for treatment of cancer and dermatological diseases. Bioorg. Med.
Chem. 14,4323
-4340.[CrossRef][Medline]
Ohishi, K., Nishikawa, S., Nagata, T., Yamauchi, N., Shinohara,
H., Kido, J. and Ishida, H. (1995). Physiological
concentrations of retinoic acid suppress the osteoblastic differentiation of
fetal rat calvaria cells in vitro. Eur. J.
Endocrinol. 133,335
-341.
Olsen, B. R., Reginato, A. M. and Wang, W.
(2000). Bone development. Annu. Rev. Cell Dev.
Biol. 16,191
-220.[CrossRef][Medline]
Papagrigorakis, M. J., Synodinos, P. N., Daliouris, C. P. and
Metaxotou, C. (2003). De novo inv(2)(p12q34) associated with
Klippel-Feil anomaly and hypodontia. Eur. J. Pediatr.
162,594
-597.[CrossRef][Medline]
Piotrowski, T., Schilling, T. F., Brand, M., Jiang, Y. J.,
Heisenberg, C. P., Beuchle, D., Grandel, H., van Eeden, F. J., Furutani-Seiki,
M., Granato, M. et al. (1996). Jaw and branchial arch mutants
in zebrafish II: anterior arches and cartilage differentiation.
Development 123,345
-356.[Abstract]
Prince, V. E., Joly, L., Ekker, M. and Ho, R. K.
(1998). Zebrafish hox genes: genomic organization and modified
colinear expression patterns in the trunk. Development
125,407
-420.[Abstract]
Reijntjes, S., Rodaway, A. and Maden, M.
(2007). The retinoic acid metabolising gene, CYP26B1, patterns
the cartilaginous cranial neural crest in zebrafish. Int. J. Dev.
Biol. 51,351
-360.[CrossRef][Medline]
Rhodes, J., Hagen, A., Hsu, K., Deng, M., Liu, T. X., Look, A.
T. and Kanki, J. P. (2005). Interplay of pu.1 and gata1
determines myelo-erythroid progenitor cell fate in zebrafish. Dev.
Cell 8,97
-108.[CrossRef][Medline]
Schilling, T. F. and Kimmel, C. B. (1997).
Musculoskeletal patterning in the pharyngeal segments of the zebrafish embryo.
Development 124,2945
-2960.[Abstract]
Shelton, D. N., Sandoval, I. T., Eisinger, A., Chidester, S.,
Ratnayake, A., Ireland, C. M. and Jones, D. A. (2006).
Up-regulation of CYP26A1 in adenomatous polyposis coli-deficient vertebrates
via a WNT-dependent mechanism: implications for intestinal cell
differentiation and colon tumor development. Cancer
Res. 66,7571
-7577.
Song, H. M., Nacamuli, R. P., Xia, W., Bari, A. S., Shi, Y. Y.,
Fang, T. D. and Longaker, M. T. (2005). High-dose retinoic
acid modulates rat calvarial osteoblast biology. J. Cell
Physiol. 202,255
-262.[CrossRef][Medline]
Spoorendonk, K. M., Peterson-Maduro, J., Renn, J., Trowe, T.,
Kranenbarg, S., Winkler, C. and Schulte-Merker, S. (2008).
Retinoic acid and Cyp26b1 are critical regulators of osteogenesis in the axial
skeleton. Development
135,3765
-3774.
Stemple, D. (2005). Structure and function of
the notochord: an essential organ for chordate development.
Development 132,2503
-2512.
Stoppie, P., Borgers, M., Borghgraef, P., Dillen, L., Goossens,
J., Sanz, G., Szel, H., Van Hove, C., Van Nyen, G., Nobels, G. et al.
(2000). R115866 inhibits all-trans-retinoic acid metabolism and
exerts retinoidal effects in rodents. J. Pharmacol. Exp.
Ther. 293,304
-312.
Tahayato, A., Dolle, P. and Petkovich, M.
(2003). Cyp26C1 encodes a novel retinoic acid-metabolizing enzyme
expressed in the hindbrain, inner ear, first branchial arch and tooth buds
during murine development. Gene Expr. Patterns
3, 449-454.[CrossRef][Medline]
Tracy, M. R., Dormans, J. P. and Kusumi, K.
(2004). Klippel-Feil syndrome: clinical features and current
understanding of etiology. Clin. Orthop. Relat. Res.
424,183
-190.[CrossRef][Medline]
Ulsamer, A., Ortuno, M. J., Ruiz, S., Susperregui, A. R., Osses,
N., Rosa, J. L. and Ventura, F. (2008). BMP-2 induces Osterix
expression through up-regulation of Dlx5 and its phosphorylation by p38.
J. Biol. Chem. 283,3816
-3826.
Wada, N., Javidan, Y., Nelson, S., Carney, T. J., Kelsh, R. N.
and Schilling, T. F. (2005). Hedgehog signaling is required
for cranial neural crest morphogenesis and chondrogenesis at the midline in
the zebrafish skull. Development
132,3977
-3988.
Walker, M. B. and Kimmel, C. B. (2007). A
two-color acid-free cartilage and bone stain for zebrafish larvae.
Biotech. Histochem. 82,23
-28.[CrossRef][Medline]
Weston, A. D., Hoffman, L. M. and Underhill, T. M.
(2003). Revisiting the role of retinoid signaling in skeletal
development. Birth Defects Res. C Embryo Today
69,156
-173.[CrossRef][Medline]
White, J. A., Beckett-Jones, B., Guo, Y. D., Dilworth, F. J.,
Bonasoro, J., Jones, G. and Petkovich, M. (1997). cDNA
cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a
novel family of cytochromes P450. J. Biol. Chem.
272,18538
-18541.
White, R. J., Nie, Q., Lander, A. D. and Schilling, T. F.
(2007). Complex regulation of cyp26a1 creates a robust retinoic
acid gradient in the zebrafish embryo. PLoS Biol.
5, e304.[CrossRef][Medline]
Wienholds, E., van Eeden, F., Kosters, M., Mudde, J., Plasterk,
R. H. and Cuppen, E. (2003). Efficient target-selected
mutagenesis in zebrafish. Genome Res.
13,2700
-2707.
Witten, P. E., Hansen, A. and Hall, B. K.
(2001). Features of mono- and multinucleated bone resorbing cells
of the zebrafish Danio rerio and their contribution to skeletal development,
remodeling, and growth. J. Morphol.
250,197
-207.[CrossRef][Medline]
Wu, X., Shi, W. and Cao, X. (2007).
Multiplicity of BMP signaling in skeletal development. Ann. N. Y.
Acad. Sci. 1116,29
-49.[CrossRef][Medline]
Yan, Y.-L., Hatta, K., Riggleman, B. and Postlethwait, J. H.
(1995). Expression of a type II collagen gene in the zebrafish
embryonic axis. Dev. Dyn.
203,363
-376.[Medline]
Yashiro, K., Zhao, X., Uehara, M., Yamashita, K., Nishijima, M.,
Nishino, J., Saijoh, Y., Sakai, Y. and Hamada, H. (2004).
Regulation of retinoic acid distribution is required for proximodistal
patterning and outgrowth of the developing mouse limb. Dev.
Cell 6,411
-422.[CrossRef][Medline]
Young, D. L., Schneider, R. A., Hu, D. and Helms, J. A.
(2000). Genetic and teratogenic approaches to craniofacial
development. Crit. Rev. Oral Biol. Med.
11,304
-317.
Zhao, Q., Dobbs-McAuliffe, B. and Linney, E.
(2005). Expression of cyp26b1 during zebrafish early development.
Gene Expr. Patterns 5,363
-369.[CrossRef][Medline]
Zhao, Q., Shao, J., Chen, W. and Li, Y. P.
(2007). Osteoclast differentiation and gene regulation.
Front. Biosci. 12,2519
-2529.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
K. M. Spoorendonk, J. Peterson-Maduro, J. Renn, T. Trowe, S. Kranenbarg, C. Winkler, and S. Schulte-Merker Retinoic acid and Cyp26b1 are critical regulators of osteogenesis in the axial skeleton Development, November 15, 2008; 135(22): 3765 - 3774. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||